Company / Current Liabilities per Share
Ovid Therapeutics Inc. Current Liabilities per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.12
FY2025
5-year range
$0.10 / $0.16
FY2022-FY2025
Trend
-21.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.16 to $0.12 over the past 2 years.
Based on SEC 10-K filings.
0.12 in FY2025 with a 3-year CAGR of +5.5%.
Improved from $0.16 to $0.12 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +5.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 21.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.12 | -21.6% |
| FY2024 | $0.15 | -8.6% |
| FY2023 | $0.16 | +63.9% |
| FY2022 | $0.10 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026